PortfoliosLab logo

BioCryst Pharmaceuticals, Inc. (BCRX)

Equity · Currency in USD · Last updated Mar 18, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in BioCryst Pharmaceuticals, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $12,462 for a total return of roughly 24.62%. All prices are adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%10.00%NovemberDecember2023FebruaryMarch
-36.72%
6.48%
BCRX (BioCryst Pharmaceuticals, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BCRX

BioCryst Pharmaceuticals, Inc.

Return

BioCryst Pharmaceuticals, Inc. had a return of -29.44% year-to-date (YTD) and -47.64% in the last 12 months. Over the past 10 years, BioCryst Pharmaceuticals, Inc. had an annualized return of 19.82%, outperforming the S&P 500 benchmark which had an annualized return of 9.71%.


PeriodReturnBenchmark
1 month-21.66%-5.31%
Year-To-Date-29.44%2.01%
6 months-36.87%0.39%
1 year-47.64%-10.12%
5 years (annualized)8.58%7.32%
10 years (annualized)19.82%9.71%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-8.10%-16.11%
2022-9.35%5.95%0.07%-14.07%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current BioCryst Pharmaceuticals, Inc. Sharpe ratio is -0.64. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.000.20NovemberDecember2023FebruaryMarch
-0.64
-0.43
BCRX (BioCryst Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividend History


BioCryst Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%NovemberDecember2023FebruaryMarch
-75.55%
-18.34%
BCRX (BioCryst Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the BioCryst Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the BioCryst Pharmaceuticals, Inc. is 97.74%, recorded on Jul 3, 2002. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.74%Aug 28, 2000462Jul 3, 2002
-75.99%Jun 19, 1996581Oct 7, 1998212Aug 11, 1999793
-50.76%Mar 9, 200028Apr 17, 200074Aug 2, 2000102
-47.17%Mar 11, 199428Apr 20, 1994222Mar 13, 1995250
-40.78%Jun 19, 19952Jun 20, 1995209Apr 18, 1996211
-35.94%Aug 25, 199973Dec 7, 199960Mar 3, 2000133
-22.41%Apr 22, 199613May 8, 199611May 23, 199624
-16.67%Mar 23, 199536May 12, 199512May 31, 199548
-8.82%May 24, 19962May 28, 19964Jun 3, 19966
-8.77%Aug 18, 19991Aug 18, 19994Aug 24, 19995

Volatility Chart

Current BioCryst Pharmaceuticals, Inc. volatility is 26.75%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%NovemberDecember2023FebruaryMarch
26.75%
21.17%
BCRX (BioCryst Pharmaceuticals, Inc.)
Benchmark (^GSPC)